A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer M.A.M. Osman1, R. McDermott2 and D. Fennelly1 1Department of Oncology, St Vincents University Hospital, Dublin, Ireland 2Department of Medical Oncology, AMNCH Adelaide and Meath Hospital, Dublin, Ireland Background: Nab-Paclitaxel in combination withGemcitabine has significantly improved outcomes in advanced pancreatic cancer.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with AMNCH
Contact AMNCH, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack